InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Schulman Amy W, Director. Insider active across 5 companies, notably Elevance Health, Inc.. In total, 13 reports have been published. Split: 2 buys · 1 sell. Total volume traded: €33k. Activity tracked since 13 December 2021. The latest transaction was disclosed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Schulman Amy W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
838 股0Common StockSEC:0001178670-26-000041:0
563 股0Common StockSEC:0001438226-26-000009:0
11,250 股@ US$70.200.0018% mcap100.0% 占其流量Common StockSEC:0001178670-26-000017:0
26 股@ US$287.500.0000% mcap50.0% 占其流量Common StockSEC:0001438226-26-000007:0
218 股0Common StockSEC:0001438226-26-000005:0
775 股0Common StockSEC:0001735276-25-000061:0
8,550 股@ US$1.1654100.0% 占其流量Common StockSEC:0000950170-25-040466:0
标准退出：2025年6月11日 (T+90)
2,750 股@ US$131.218.5% 占其流量Common StockSEC:0001735276-25-000037:0
8,500 股@ US$131.2126.7% 占其流量Common StockSEC:0001735276-24-000072:0
30,000 股@ US$66.8347.6% 占其流量Common StockSEC:0001735276-24-000058:0
136 股0Common StockSEC:0001735276-23-000019:0
10,091 股@ US$2.0225.2% 占其流量Common StockSEC:0001209191-21-071110:0
1,850 股@ US$10.8824.8% 占其流量Common StockSEC:0001209191-21-069790:0
标准退出：2022年3月13日 (T+90)
13 条申报中的 13 条
About Schulman Amy W
Amy W. Schulman is a Director at Elevance Health, Inc. and Alnylam Pharmaceuticals, Inc. She brings her expertise in strategy and governance to the board. Elevance Health is a healthcare services company, while Alnylam Pharmaceuticals focuses on developing innovative therapies. Ms. Schulman plays an active role in strategic direction and oversight of the companies' operations.
